We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Union Sues J&J for Blocking Biosimilar, Generics Competition
Union Sues J&J for Blocking Biosimilar, Generics Competition
A worker benefits fund filed a lawsuit against Johnson & Johnson this week for allegedly maintaining an illegal monopoly for its Crohn’s disease drug Remicade.